These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 23469931

  • 1. Natriuretic peptides induce weak VASP phosphorylation at Serine 239 in platelets.
    Borgognone A, Lowe KL, Watson SP, Madhani M.
    Platelets; 2014; 25(1):1-7. PubMed ID: 23469931
    [Abstract] [Full Text] [Related]

  • 2. Dipyridamole synergizes with nitric oxide to prolong inhibition of thrombin-induced platelet shape change.
    Jensen BO, Kleppe R, Kopperud R, Nygaard G, Døskeland SO, Holmsen H, Selheim F.
    Platelets; 2011; 22(1):8-19. PubMed ID: 20958117
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations.
    Lee HS, Kim SD, Lee WM, Endale M, Kamruzzaman SM, Oh WJ, Cho JY, Kim SK, Cho HJ, Park HJ, Rhee MH.
    Eur J Pharmacol; 2010 Feb 10; 627(1-3):85-91. PubMed ID: 19913011
    [Abstract] [Full Text] [Related]

  • 7. Reduction of cAMP and cGMP inhibitory effects in human platelets by MRP4-mediated transport.
    Borgognone A, Pulcinelli FM.
    Thromb Haemost; 2012 Nov 10; 108(5):955-62. PubMed ID: 23014861
    [Abstract] [Full Text] [Related]

  • 8. Phosphorylation of the vasodilator-stimulated phosphoprotein (VASP) by the anti-platelet drug, cilostazol, in platelets.
    Sudo T, Ito H, Kimura Y.
    Platelets; 2003 Sep 10; 14(6):381-90. PubMed ID: 14602552
    [Abstract] [Full Text] [Related]

  • 9. A predominant role for cAMP-dependent protein kinase in the cGMP-induced phosphorylation of vasodilator-stimulated phosphoprotein and platelet inhibition in humans.
    Li Z, Ajdic J, Eigenthaler M, Du X.
    Blood; 2003 Jun 01; 101(11):4423-9. PubMed ID: 12576312
    [Abstract] [Full Text] [Related]

  • 10. Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition.
    Horstrup K, Jablonka B, Hönig-Liedl P, Just M, Kochsiek K, Walter U.
    Eur J Biochem; 1994 Oct 01; 225(1):21-7. PubMed ID: 7925440
    [Abstract] [Full Text] [Related]

  • 11. Globular adiponectin increases cGMP formation in blood platelets independently of nitric oxide.
    Riba R, Patel B, Aburima A, Naseem KM.
    J Thromb Haemost; 2008 Dec 01; 6(12):2121-31. PubMed ID: 18983522
    [Abstract] [Full Text] [Related]

  • 12. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
    Bilodeau ML, Hamm HE.
    J Pharmacol Exp Ther; 2007 Aug 01; 322(2):778-88. PubMed ID: 17525299
    [Abstract] [Full Text] [Related]

  • 13. Antiplatelet effects of caffeic acid due to Ca(2＋) mobilizationinhibition via cAMP-dependent inositol-1, 4, 5-trisphosphate receptor phosphorylation.
    Lee DH, Kim HH, Cho HJ, Bae JS, Yu YB, Park HJ.
    J Atheroscler Thromb; 2014 Aug 01; 21(1):23-37. PubMed ID: 24088646
    [Abstract] [Full Text] [Related]

  • 14. Specific inhibitory effects of the NO donor MAHMA/NONOate on human platelets.
    Kobsar A, Simonis S, Klinker E, Koessler A, Kuhn S, Boeck M, Koessler J.
    Eur J Pharmacol; 2014 Jul 15; 735():169-76. PubMed ID: 24780647
    [Abstract] [Full Text] [Related]

  • 15. Dipyridamole enhances NO/cGMP-mediated vasodilator-stimulated phosphoprotein phosphorylation and signaling in human platelets: in vitro and in vivo/ex vivo studies.
    Aktas B, Utz A, Hoenig-Liedl P, Walter U, Geiger J.
    Stroke; 2003 Mar 15; 34(3):764-9. PubMed ID: 12624305
    [Abstract] [Full Text] [Related]

  • 16. Monomeric C-reactive protein is prothrombotic and dissociates from circulating pentameric C-reactive protein on adhered activated platelets under flow.
    Molins B, Peña E, de la Torre R, Badimon L.
    Cardiovasc Res; 2011 Nov 01; 92(2):328-37. PubMed ID: 21859817
    [Abstract] [Full Text] [Related]

  • 17. Synergistic phosphorylation of the focal adhesion-associated vasodilator-stimulated phosphoprotein in intact human platelets in response to cGMP- and cAMP-elevating platelet inhibitors.
    Nolte C, Eigenthaler M, Horstrup K, Hönig-Liedl P, Walter U.
    Biochem Pharmacol; 1994 Oct 18; 48(8):1569-75. PubMed ID: 7980622
    [Abstract] [Full Text] [Related]

  • 18. The mediation of platelet quiescence by NO-releasing polymers via cGMP-induced serine 239 phosphorylation of vasodilator-stimulated phosphoprotein.
    Major TC, Handa H, Brisbois EJ, Reynolds MM, Annich GM, Meyerhoff ME, Bartlett RH.
    Biomaterials; 2013 Nov 18; 34(33):8086-96. PubMed ID: 23906514
    [Abstract] [Full Text] [Related]

  • 19. Glucagon-like peptide 1-related peptides increase nitric oxide effects to reduce platelet activation.
    Barale C, Buracco S, Cavalot F, Frascaroli C, Guerrasio A, Russo I.
    Thromb Haemost; 2017 Jun 02; 117(6):1115-1128. PubMed ID: 28405672
    [Abstract] [Full Text] [Related]

  • 20. Regulation of cGMP by soluble and particulate guanylyl cyclases in cultured human airway smooth muscle.
    Hamad AM, Range S, Holland E, Knox AJ.
    Am J Physiol; 1997 Oct 02; 273(4):L807-13. PubMed ID: 9357856
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.